VBI Vaccines Inc. (VBIV)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.6085 |
| Open | 0.5936 |
| Bid | 0.5604 x 300 |
| Ask | 0.6175 x 400 |
| Day's range | 0.5802 - 0.6100 |
| 52-week range | 0.4500 - 3.4700 |
| Volume | |
| Avg. volume | 463,906 |
| Market cap | 16.775M |
| Beta (5Y monthly) | 1.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
Puma Biotech (PBYI) delivered earnings and revenue surprises of 42.86% and 6.29%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
VBI Vaccines Inc.'s (NASDAQ:VBIV) Intrinsic Value Is Potentially 30% Above Its Share Price
Key Insights The projected fair value for VBI Vaccines is US$3.70 based on 2 Stage Free Cash Flow to Equity Current...
- Zacks
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue Estimates
VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -7.05% and 40.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.